IBDEI1RC ; ; 17-FEB-2016
 ;;3.0;IB ENCOUNTER FORM IMP/EXP;;JUN 29, 2015
 Q:'DIFQR(358.3)  F I=1:2 S X=$T(Q+I) Q:X=""  S Y=$E($T(Q+I+1),4,999),X=$E(X,4,999) S:$A(Y)=126 I=I+1,Y=$E(Y,2,999)_$E($T(Q+I+1),5,99) S:$A(Y)=61 Y=$E(Y,2,999) X NO E  S @X=Y
Q Q
 ;;^UTILITY(U,$J,358.3,29853,1,1,0)
 ;;=1^J9299
 ;;^UTILITY(U,$J,358.3,29853,1,3,0)
 ;;=3^Nivolumab Inj 1mg
 ;;^UTILITY(U,$J,358.3,29854,0)
 ;;=P9010^^116^1484^22^^^^1
 ;;^UTILITY(U,$J,358.3,29854,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29854,1,1,0)
 ;;=1^P9010
 ;;^UTILITY(U,$J,358.3,29854,1,3,0)
 ;;=3^Whole Blood,Ea Unit
 ;;^UTILITY(U,$J,358.3,29855,0)
 ;;=P9012^^116^1484^4^^^^1
 ;;^UTILITY(U,$J,358.3,29855,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29855,1,1,0)
 ;;=1^P9012
 ;;^UTILITY(U,$J,358.3,29855,1,3,0)
 ;;=3^Cryoprecipitate,Ea Unit
 ;;^UTILITY(U,$J,358.3,29856,0)
 ;;=P9016^^116^1484^18^^^^1
 ;;^UTILITY(U,$J,358.3,29856,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29856,1,1,0)
 ;;=1^P9016
 ;;^UTILITY(U,$J,358.3,29856,1,3,0)
 ;;=3^RBC Leukocytes Reduced
 ;;^UTILITY(U,$J,358.3,29857,0)
 ;;=P9017^^116^1484^6^^^^1
 ;;^UTILITY(U,$J,358.3,29857,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29857,1,1,0)
 ;;=1^P9017
 ;;^UTILITY(U,$J,358.3,29857,1,3,0)
 ;;=3^Plasma 1 Donor Frz w/in 8hrs
 ;;^UTILITY(U,$J,358.3,29858,0)
 ;;=P9019^^116^1484^10^^^^1
 ;;^UTILITY(U,$J,358.3,29858,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29858,1,1,0)
 ;;=1^P9019
 ;;^UTILITY(U,$J,358.3,29858,1,3,0)
 ;;=3^Platelets,Ea Unit
 ;;^UTILITY(U,$J,358.3,29859,0)
 ;;=P9021^^116^1484^20^^^^1
 ;;^UTILITY(U,$J,358.3,29859,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29859,1,1,0)
 ;;=1^P9021
 ;;^UTILITY(U,$J,358.3,29859,1,3,0)
 ;;=3^Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,29860,0)
 ;;=P9022^^116^1484^21^^^^1
 ;;^UTILITY(U,$J,358.3,29860,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29860,1,1,0)
 ;;=1^P9022
 ;;^UTILITY(U,$J,358.3,29860,1,3,0)
 ;;=3^Washed Red Blood Cells,Ea Unit
 ;;^UTILITY(U,$J,358.3,29861,0)
 ;;=P9023^^116^1484^5^^^^1
 ;;^UTILITY(U,$J,358.3,29861,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29861,1,1,0)
 ;;=1^P9023
 ;;^UTILITY(U,$J,358.3,29861,1,3,0)
 ;;=3^Frozen Plasma,Pooled,SD
 ;;^UTILITY(U,$J,358.3,29862,0)
 ;;=P9034^^116^1484^12^^^^1
 ;;^UTILITY(U,$J,358.3,29862,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29862,1,1,0)
 ;;=1^P9034
 ;;^UTILITY(U,$J,358.3,29862,1,3,0)
 ;;=3^Platelets,Pheresis
 ;;^UTILITY(U,$J,358.3,29863,0)
 ;;=P9035^^116^1484^8^^^^1
 ;;^UTILITY(U,$J,358.3,29863,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29863,1,1,0)
 ;;=1^P9035
 ;;^UTILITY(U,$J,358.3,29863,1,3,0)
 ;;=3^Platelet Pheres Leuko Reduced
 ;;^UTILITY(U,$J,358.3,29864,0)
 ;;=P9036^^116^1484^9^^^^1
 ;;^UTILITY(U,$J,358.3,29864,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29864,1,1,0)
 ;;=1^P9036
 ;;^UTILITY(U,$J,358.3,29864,1,3,0)
 ;;=3^Platelet Pheres Leukoredu Irrad
 ;;^UTILITY(U,$J,358.3,29865,0)
 ;;=P9038^^116^1484^16^^^^1
 ;;^UTILITY(U,$J,358.3,29865,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29865,1,1,0)
 ;;=1^P9038
 ;;^UTILITY(U,$J,358.3,29865,1,3,0)
 ;;=3^RBC Irradiated
 ;;^UTILITY(U,$J,358.3,29866,0)
 ;;=P9039^^116^1484^15^^^^1
 ;;^UTILITY(U,$J,358.3,29866,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29866,1,1,0)
 ;;=1^P9039
 ;;^UTILITY(U,$J,358.3,29866,1,3,0)
 ;;=3^RBC Deglycerolized
 ;;^UTILITY(U,$J,358.3,29867,0)
 ;;=P9040^^116^1484^17^^^^1
 ;;^UTILITY(U,$J,358.3,29867,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29867,1,1,0)
 ;;=1^P9040
 ;;^UTILITY(U,$J,358.3,29867,1,3,0)
 ;;=3^RBC Leuko Reduced Irradiated
 ;;^UTILITY(U,$J,358.3,29868,0)
 ;;=P9044^^116^1484^3^^^^1
 ;;^UTILITY(U,$J,358.3,29868,1,0)
 ;;=^358.31IA^3^2
 ;;^UTILITY(U,$J,358.3,29868,1,1,0)
 ;;=1^P9044
 ;;^UTILITY(U,$J,358.3,29868,1,3,0)
 ;;=3^Cryoprecip Reduced Plasma
 ;;^UTILITY(U,$J,358.3,29869,0)
 ;;=P9051^^116^1484^1^^^^1
 ;;^UTILITY(U,$J,358.3,29869,1,0)
 ;;=^358.31IA^3^2
